Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference26 articles.
1. US Food and Drug Administration. In vitro metabolism- and transporter-mediated drug-drug interaction studies. Guidance for industry. 2020. https://www.fda.gov/media/134582/download. Accessed 17 Feb 2021.
2. Chu X, Liao M, Shen H, Yoshida K, Zur AA, Arya V, et al. Clinical probes and endogenous biomarkers as substrates for transporter drug-drug interaction evaluation: perspectives from the International Transporter Consortium. Clin Pharmacol Ther. 2018;104(5):836–64.
3. EMEA. Guideline on the investigation of drug interactions. 2012 (cited 2020). https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-drug-interactions_en.pdf. Accessed 18 Feb 2020.
4. Guest EJ, Rowland-Yeo K, Rostami-Hodjegan A, Tucker GT, Houston JB, Galetin A. Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models. Br J Clin Pharmacol. 2011;71(1):72–87.
5. Peters SA, Schroeder PE, Giri N, Dolgos H. Evaluation of the use of static and dynamic models to predict drug-drug interaction and its associated variability: impact on drug discovery and early development. Drug Metab Dispos. 2012;40(8):1495–507.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献